Mumbai, Sep 22 (UNI) Institute of Life Sciences (ILS) and Aptuit Laurus have signed an agreement for joint research collaboration to enhance drug research and discovery programs going on at the institute.
As part of this collaboration, both ILS and Aptuit Laurus would provide expertise and would be working in the area of Human Histone Deacetylase Proteins in relation to metabolic disorders (like diabetes). ILS will also provide incubation and training in the initial phase of the collaboration.
In a statement here today, Dr Javed Iqbal Director, Institute of Life Sciences said, ''ILS is a unique model of high quality research in the country with an emphasis on translational research with focus in identifying novel therapies for neglected diseases and metabolic disorders. This collaboration opens up great opportunities for world class research at ILS and is part of our ongoing efforts to enter into research partnerships with pharmaceutical and biotechnology companies''.
''Aptuit Laurus has unique capabilities in offering a wide range of services to accelerate the drug discovery and development process.
We are interested in collaborating with Institutes of eminence worldwide and this research collaboration with ILS is one such step to achieving our objectives and provide world class service,'' Dr Satyanarayana, CEO of Aptuit Laurus, said.
UNI AR SR NP1937